These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 309192)

  • 1. Heparin neutralizing activity in patients with renal disease on maintenance haemodialysis.
    Aronstam A; Dennis B; Friesen MJ; Clark WF; Linton AL; Lindsay RM
    Thromb Haemost; 1978 Jun; 39(3):695-700. PubMed ID: 309192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary surgery in dialysis-dependent patients with end-stage renal failure with and without extracorporeal circulation.
    Tugtekin S; Kappert U; Jarny K; Knaut M; Cichon R; Alexiou K; Matschke K
    Thorac Cardiovasc Surg; 2007 Mar; 55(2):84-8. PubMed ID: 17377859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease.
    Martín J; de Sequera P; Quiroga JA; Rico M; Fernández M; Arocena C; Caramelo C; Carreño V
    Cytokine; 2000 Aug; 12(8):1248-52. PubMed ID: 10930306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac surgery in patients with dialysis-dependent renal disease.
    Suehiro S; Shibata T; Sasaki Y; Murakami T; Hosono M; Fujii H; Kinoshita H
    Ann Thorac Cardiovasc Surg; 1999 Dec; 5(6):376-81. PubMed ID: 10637387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.
    Ibels LS; Stewart JH; Mahony JF; Neale FC; Sheil AG
    Q J Med; 1977 Apr; 46(182):197-214. PubMed ID: 325593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of coronary artery bypass grafting surgery with aprotinin in a patient undergoing chronic haemodialysis].
    Ueyama K; Ohashi H; Tsutsumi Y; Murakami A; Fukahara K; Fujii S; Abe Y; Ohnaka M
    Kyobu Geka; 1994 Apr; 47(4):288-90. PubMed ID: 7512168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin dosage in extracorporeal circulation and its neutralization.
    Nyman D; Thurnherr N; Duckert F
    Thromb Diath Haemorrh; 1975 Feb; 33(1):102-4. PubMed ID: 1118825
    [No Abstract]   [Full Text] [Related]  

  • 10. Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis.
    Macdonald JA; McDonald SP; Hawley CM; Rosman J; Brown F; Wiggins KJ; Bannister K; Johnson DW
    Nephrol Dial Transplant; 2009 Sep; 24(9):2825-31. PubMed ID: 19443649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin and heparin during haemodialysis: comparative effects.
    Camici M; Evangelisti L
    Life Support Syst; 1986; 4(3):205-9. PubMed ID: 3537544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of risk-adjusted, non-dialysis-dependent renal dysfunction on mortality and morbidity following coronary artery bypass surgery: a multi-centre study.
    Devbhandari MP; Duncan AJ; Grayson AD; Fabri BM; Keenan DJ; Bridgewater B; Jones MT; Au J;
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):964-70. PubMed ID: 16675230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
    Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL
    Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
    Andrassy K
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S39-43. PubMed ID: 8180328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure.
    Bosch T; Thiery J; Gurland HJ; Seidel D
    Nephrol Dial Transplant; 1993; 8(12):1350-8. PubMed ID: 8159304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haemodialysis in children (author's transl)].
    Wolf A; Balzar E; Pinggera WF; Stummvoll HK
    Wien Klin Wochenschr; 1980 Jan; 92(2):35-42. PubMed ID: 6990630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
    Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.